Picture of Alpine Immune Sciences logo

ALPN — Alpine Immune Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Alpine Immune Sciences Provides Corporate Update And Reports First Quarter 2021 Financial Results

May 13 (Reuters) - Alpine Immune Sciences Inc  ALPN.O :
    * ALPINE IMMUNE SCIENCES PROVIDES CORPORATE UPDATE AND
REPORTS
FIRST QUARTER 2021 FINANCIAL RESULTS
    * ALPINE IMMUNE SCIENCES - EXPECTS ITS CURRENT CASH
RESOURCES ARE
SUFFICIENT TO FUND PLANNED OPERATIONS THROUGH 2023
    * QTRLY BASIC AND DILUTED NET LOSS PER SHARE $0.45
    * Q1 EARNINGS PER SHARE VIEW $-0.36, REVENUE VIEW $5.6
MILLION --
REFINITIV IBES DATA
    * ALPINE IMMUNE SCIENCES - SEES CURRENT CASH RESOURCES,
POTENTIAL
PRE-OPTION EXERCISE MILESTONES PAYABLE SUFFICIENT TO FUND
PLANNED OPERATIONS THROUGH 2023

Source text for Eikon:  ID:nBw4bVy18a 
Further company coverage:  ALPN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Alpine Immune Sciences

See all news